Table of Contents
Why Methodologically Supported Use of MLS Laser, Shockwave, and Orthobiologics Strengthens Causation Reliability
Trial attorneys preparing expert testimony frequently encounter reliability challenges when advanced modalities appear in a personal-injury file. Defense counsel often argue that MLS laser therapy, extracorporeal shockwave therapy (ESWT), or orthobiologics such as platelet-rich plasma (PRP) rest on unproven theories rather than reliable methodology. Courts applying Daubert standards or Federal Rule of Evidence 702 look for a clear, testable connection between the trauma, the objective findings, and the subsequent care. Opinions that introduce advanced treatments before establishing traumatic findings are vulnerable. Dual-scope protocols reverse that sequence and produce more durable testimony.

The Core Reliability Problem
Expert opinions fail reliability scrutiny for several common reasons:
- Treatment recommendations appear before objective traumatic findings are recorded
- Parameters of the advanced modality are not documented or tied to published ranges
- Alternative explanations (pre-existing degeneration, unrelated conditions) are not addressed
- The file lacks dual-scope co-signature linking biomechanical and medical findings
- Conclusions leap from biologic plausibility to a specific intervention without intermediate measurements
A methodologically supported approach closes these gaps by requiring objective traumatic evidence first.
Dual-Scope Protocol: Objective Findings Before Advanced Modalities
The sequence begins with standard elements of a defensible causation analysis:
- Reconstructed pre-injury baseline
- Documented mechanism of trauma (for example, rapid deceleration on I-10 or Loop 375)
- Temporal correlation of symptom onset
- Objective measurements that isolate traumatic change
Key measurements typically include:
- Digital range-of-motion analysis
- Alteration of motion segment integrity (AOMSI) from flexion-extension radiographs
- Timed MRI morphology and disc-height data
- Selected inflammatory or metabolic laboratory markers when clinically indicated
Only after these findings confirm a traumatic contribution does the team consider MLS laser, shockwave, or orthobiologics. Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, documents the structural and soft-tissue findings. Dr. Maria Guadalupe Cardenas, MD, provides medical direction for laboratory interpretation, risk stratification, and internal-medicine context. The co-signed record therefore shows both the biomechanical injury and the medical setting before any advanced intervention.
This order prevents the analytical gap that courts reject. The expert is not claiming that the modality itself proves causation. The expert is showing that objective findings already establish traumatic aggravation under the Texas Eggshell Plaintiff rule and that later evidence-aligned care was medically reasonable because those findings existed.
Evidence-Aligned Use of MLS Laser Therapy
The MLS laser delivers synchronized 808 nm and 905 nm wavelengths. Protocols typically target energy densities of 4–10 J/cm² for musculoskeletal tissue. Dual-scope notes record:
- Pre-treatment objective measurements
- Specific energy density and treatment sites
- Post-treatment changes in motion or pain scores
- Any concurrent orthobiologic procedures
Registry observations have shown faster pain reduction and higher long-term satisfaction when MLS is paired with orthobiologics compared with orthobiologics alone. Because the traumatic baseline is already documented, the laser sessions function as a tracked adjunct rather than an unanchored experimental treatment.
Evidence-Aligned Use of Shockwave Therapy
Extracorporeal shockwave therapy is limited to conditions with supporting literature (certain tendinopathies or myofascial patterns already linked to the trauma mechanism). Documentation includes:
- Number of pulses and energy flux density
- Targeted structures confirmed by examination or imaging
- Pre- and post-treatment functional measures
- Rationale for combining with PRP or related orthobiologics when used
The record shows that shockwave was applied only after traumatic soft-tissue findings were established, not as a first-line or speculative intervention.
Evidence-Aligned Use of Orthobiologics
Autologous preparations such as PRP or PRF are considered only under medical direction and only when objective findings support the indication. Typical documentation elements include:
- Clinical indication tied to measured traumatic change (for example, persistent ligamentous laxity confirmed by AOMSI)
- Exclusion or quantification of higher-risk alternatives
- Injection details and guidance method
- Serial functional testing that tracks measurable response
The dual-scope baseline prevents the claim that the orthobiologic was an experimental treatment introduced without supporting findings.
How the Protocol Meets Reliability Standards
Reliability under Daubert and FRE 702 is strengthened because:
- Objective measurements are reproducible and controlled by published methodology (including AMA Guides approaches to AOMSI)
- Advanced modalities are applied within published parameter ranges and fully recorded
- Alternative explanations are explicitly considered and either excluded or quantified
- The sequence of findings before treatment is visible in the dated record
- Dual-scope co-signature links structural and medical observations
Attorneys can demonstrate that the expert did not select the modality first and then search for supporting findings. The findings came first. The modality followed only when the findings justified it.
Bioethical Pillars Supporting the Approach
Beneficence. Evidence-aligned use of MLS laser, shockwave, and orthobiologics after objective traumatic findings aims to support tissue-level healing and functional restoration rather than temporarily suppress symptoms.
Non-Maleficence. Restricting these modalities to cases with measured traumatic findings and documented parameters drawn from published ranges reduces the risk of applying unvalidated interventions that could later be challenged as unnecessary or experimental.
Autonomy. Patients and counsel receive the same objective measurements, the same rationale for each modality, and the same serial tracking data. Informed decisions rest on shared, transparent records.
What makes Dr. Jimenez’s Injury Medical Chiropractic and Functional Medicine Clinic unique
What makes Dr. Jimenez’s Injury Medical Chiropractic and Functional Medicine Clinic unique is combining a medical director with a dual-licensed soft-tissue specialist under one roof.
- Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine with more than forty years of experience, serves as Medical Director and provides internal medicine oversight for complex comorbidities, laboratory interpretation, and risk stratification.
- Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, brings both chiropractic expertise in soft-tissue and spinal biomechanics and advanced-practice nursing credentials (Texas License #1191402, Prescriptive Authority #59628) that allow integrated diagnostic and treatment decisions.
- This dual-scope model at Injury Medical Clinic PA in El Paso, Texas, is one of the only clinics in the region that can document objective traumatic findings and then apply evidence-aligned MLS laser, shockwave, and orthobiologic protocols under coordinated medical direction. The result is a single, co-signed record that attorneys can rely on for both clinical care and causation reliability.
Further detail on the dual-scope approach to medical-legal causation appears in the comprehensive guide at dralexjimenez.com.
Related discussions of MLS laser parameters and registry outcomes are available at the MLS laser guide, while the synergistic use of shockwave and PRP is examined at the regenerative combination article.
Attorneys evaluating expert testimony standards will also find the clinic’s approach to Daubert-compliant documentation outlined at the expert-witness resource.
Cross-Domain Anchor: The reliability framework is explained in the medical-legal causation documentation guide at dralexjimenez.com.
Attorneys preparing cases that must withstand reliability challenges can request the dual-scope records that place objective traumatic findings first and evidence-aligned advanced modalities second. The resulting documentation supplies the consistent, methodologically supported foundation required for durable expert testimony.
References
Anders, J. J., Lanzafame, R. J., & Arany, P. R. (2015). Low-level light/laser therapy versus photobiomodulation therapy. Photomedicine and Laser Surgery, 33(4), 183–184. doi.org/10.1089/pho.2015.9848
Hamblin, M. R. (2016). Shining light on the head: Photobiomodulation for brain disorders. BBA Clinical, 6, 113–124. doi.org/10.1016/j.bbacli.2016.09.002
Schmitz, C., Császár, N. B. M., Milz, S., Schieker, M., Maffulli, N., Rompe, J. D., & Furia, J. P. (2015). Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: A systematic review of studies listed in the PEDro database. British Medical Bulletin, 116(1), 115–138. doi.org/10.1093/bmb/ldv047
Vannini, F., Di Matteo, B., Filardo, G., & Kon, E. (2014). Platelet-rich plasma for cartilage healing and regeneration: A systematic review of the evidence on humans and animals. International Orthopaedics, 38(8), 1595–1603. doi.org/10.1007/s00264-014-2383-4
World Association for Laser Therapy. (2010). Recommended treatment doses for low-level laser therapy. waltza.co.za/documentation-links/recommendations
American Medical Association. (2024). AMA guides to the evaluation of permanent impairment (6th ed.). American Medical Association.
Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).
Federal Rules of Evidence, Rule 702 (2023).
State Bar of Texas. (2018). Texas pattern jury charges: General negligence & intentional personal torts. State Bar of Texas.
Jimenez, A. (2026). A comprehensive guide about MLS laser therapy & photobiomodulation. Injury Medical Clinic PA. dralexjimenez.com/a-comprehensive-guide-about-mls-laser-therapy-photobiomodulation
Jimenez, A. (2026). A deep dive into regenerative medicine: Unlocking the synergistic power of shockwave therapy and platelet-rich plasma (PRP). Injury Medical Clinic PA. dralexjimenez.com/a-deep-dive-into-regenerative-medicine-unlocking-the-synergistic-power-of-shockwave-therapy-and-platelet-rich-plasma-prp
Jimenez, A. (2026). El Paso injury causation: Connecting accidents to injuries. Injury Medical Clinic PA. dralexjimenez.com/el-paso-injury-causation-connecting-accidents-to-injuries


Again, We Welcome You.
Comments are closed.